Back to Search
DEREK BUDMAN, D.M.D.
D.M.D.
Dentist
NPI: 1417095027Individual
Specialties, Licenses & Credentials
DentistPrimary
Dentist
Code: 122300000X
DN013048(GA)21383(TX)
Research & Publications (20)
Hypersensitivity to oxaliplatin: an investigation of incidence and risk factors, and literature review.
PMID 19246947·Oncology·2009
8-other
Adjuvant chemotherapy for early breast cancer in the elderly.
PMID 19360475·Curr Treat Options Oncol·2009
6-review
The hedgehog pathway as a therapeutic target for treatment of breast cancer.
PMID 19479372·Breast Cancer Res Treat·2009
6-review
Topoisomerase II{alpha} amplification does not predict benefit from dose-intense cyclophosphamide, doxorubicin, and fluorouracil therapy in HER2-amplified early breast cancer: results of CALGB 8541/150013.
PMID 19470942·J Clin Oncol·2009
8-other
In-vitro synergism of m-TOR inhibitors, statins, and classical chemotherapy: potential implications in acute leukemia.
PMID 18594212·Anticancer Drugs·2008
8-other
Implications of applied research for prognosis and therapy of breast cancer.
PMID 18243013·Crit Rev Oncol Hematol·2008
6-review
The heat shock protein 90 chaperone complex: an evolving therapeutic target.
PMID 18781898·Curr Cancer Drug Targets·2008
6-review
Heparin-induced thrombocytopenia complicating hemodialysis.
PMID 18160608·Clin Appl Thromb Hemost·2008
5-case
Influence of activation state of ErbB-2 (HER-2) on response to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for stage II, node-positive breast cancer: study 8541 from the Cancer and Leukemia Group B.
PMID 18390970·J Clin Oncol·2008
2-rct
Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B Experience.
PMID 17704418·J Clin Oncol·2007
2-rct
International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients--an analysis of the medical literature.
PMID 17488981·J Clin Oncol·2007
6-review
Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer.
PMID 17534899·Int J Cancer·2007
7-preclinical
Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis.
PMID 16821081·Breast Cancer Res Treat·2007
8-other
Fluvastatin enhancement of trastuzumab and classical cytotoxic agents in defined breast cancer cell lines in vitro.
PMID 17004104·Breast Cancer Res Treat·2007
8-other
Identification of potentially useful combinations of epidermal growth factor receptor tyrosine kinase antagonists with conventional cytotoxic agents using median effect analysis.
PMID 16940802·Anticancer Drugs·2006
8-other
Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer.
PMID 16609087·JAMA·2006
2-rct
Zoledronic acid (Zometa) enhances the cytotoxic effect of gemcitabine and fluvastatin: in vitro isobologram studies with conventional and nonconventional cytotoxic agents.
PMID 16645328·Oncology·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9201 SIENNA RANCH RD, SUITE # 102
MISSOURI CITY, TX 77459 - Phone
- (832) 886-0033
Quick Facts
- NPI
- 1417095027
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile